The purpose of our $8 million New Brunswick Innovation Research Chair Initiative (NBIRC) is to foster greater collaboration between the private sector and academia. Each of these chairs are exclusively focused on research to help private sector companies develop new and improved products and technology. This includes the development of new or existing intellectual property within your company and/or the research chair and their team.
Companies interested in exploring collaborations with one of our research chairs are invited to reach out to our team via email or phone 506-452-2884. We accept inquiries from corporations across Canada and the United States.
Please refer to the profiles of our research chairs below to discover their areas of expertise. Funding for industry-research collaborations under the NBIRC are determined on a project by project basis.
Dr. Jocelyn Paré has had a long and distinguished career as a public sector scientist with Environment Canada. Over the years, he has published over 300 papers, 2000 more of which are a result of his work. His scientific specialties include nuclear magnetic resonance spectroscopy to the analysis of contaminants in air, water, soil, plant and animal tissues; from chemical reactions caused by the impact of electrons to the structure of complex biological molecules. He is famous for developing Microwave-Assisted Processes and is the sole inventor of ten patents and co-inventor of two more.
According to the Canadian Cancer Society’s “Canadian Cancer Statistics 2014”, Atlantic Canada has the highest incidence rate in the country. With New Brunswick’s aging population, the effect of cancer on healthcare costs, life expectancy and suffering, continues to increase. By integrating his patents with, and applying his knowledge surrounding microwaves to products and research at the Atlantic Cancer Research Institute, Dr. Paré’s is developing new, non-invasive treatments more precise screening methods for detecting cancer.
As the New Brunswick Innovation Research Chair in Medical Technologies, Dr. Paré scientific and technology transfer expertise will help to position New Brunswick as a world leader in the discovery, innovation and commercialization of medical technologies. He will use his chair, network and knowledge in electromagnetic energy and microwave-assisted processing to create opportunities for multiple value-added industries including wood, food, biopharmaceuticals and bio-pesticides.
As technology advances, the demand for advanced wearable medical devices has seen a rapid increase in the past five years, including smart prosthetic hands and limbs, multi-monitoring devices for human physiology, and more recently, human performance augmentation technologies. The growth rate of the wearable medical device industry is expected to compound annually at a rate of 16%, and for multi-monitoring devices, 45%. In fact, the medical technology sector is expected to outperform pharmaceuticals by 2018. Founded in 1965, the UNB Institute for Biomedical Engineering is recognized as one of the top five research organizations of its kind in the world.
As the New Brunswick Innovation Research Chair in Medical Devices and Technology, Dr. Scheme’s mandate is to position New Brunswick as a world leader in the discovery, innovation and commercialization of medical devices and technologies. He will lead the growth of New Brunswick’s emerging medical devices industry by making it a destination of choice for new and existing companies, entrepreneurs, and exceptional students. Working with a large internal team, and from other public and private organizations, Dr. Scheme’s focus is to effectively put the results of their collective work into the hands of industry.
Dr. Erik Scheme is a Research Engineer in biological signal processing and control, human-machine interfaces, and product design at the University of New Brunswick’s Institute for Biomedical Engineering. Recipient of the 2013 Governor General’s Gold Medal for Academic Excellence, he has published articles in the Journal of Prosthetics and Orthotics, the Journal of Rehabilitation Research and Development, and others. Dr. Scheme received his PhD in Biomedical Engineering at the University of New Brunswick.
Nutrition magazines and media personalities have been hailing the positive affect of omega-3 fatty acids on human health for several years, and the food and pharmaceutical industries have followed suit. Common sources of omega-3 fatty acids currently come from animals, and most predominantly fish. However, the increased use of omega-3s in food products, nutritional supplements, and new compounds for treating inflammatory and cardiovascular diseases, discovered by Dr. Surette, is pushing demand beyond supply. This has brought a number of issues to light, including the sustainability of the fishery, and the increasing presence of toxins, like mercury, in wild fish.
As the New Brunswick Innovation Research Chair in Biosciences, Dr. Surette will work in partnership with agricultural companies to develop crops of a specific plant that is rich in a new form of omega-3 fatty acids. This will open up new opportunities for farmers in New Brunswick and beyond to grow a new and potentially lucrative crop. Dr. Surette’s aim is to work with industry to integrate these vegetable-based and sustainable fatty acids into their products. This, together with the development of new compounds for treating inflammatory and cardiovascular diseases will provide tremendous support for New Brunswick's burgeoning biomedical and pharmaceutical sectors.
Dr. Surette is a professor of chemistry and biochemistry at the Université de Moncton. A recipient of the Canada Research Chair in Cellular Lipid Metabolism, he has published over 45 articles in countless international journals including the Canadian Medical Association Journal, the Journal of Nutrition, and the International Journal of Medicinal Chemistry, to name a few, Dr. Surette completed his PhD in biochemistry at Cornell University.
Dr. Meng Gong is the Acting Director and Senior Research Scientist of the Wood Science and Technology Centre (WSTC), the University of New Brunswick (UNB). He received his Master’s degree in wood technology and Ph.D. in wood engineering from Nanjing Forestry University (China) and UNB, respectively.
As the New Brunswick Innovation Research Chair in Advanced Wood Products, Dr. Gong leads research on wood quality, wood modification and engineered wood products in the WSTC. He dedicates himself to R&D of modified wood and engineered wood products and their uses in wood building construction.
Dr. Gong is one of nine voting members since 2008 sitting on the Standing Committee on Technical Evaluations (SCTE), Canadian Commission on Construction Materials Evaluation, National Research Council. He is the only member of expertise in wood products and physically located in Atlantic Canada. As a member, Dr. Gong reviews the Scope and Evaluation Plans and Technical Guides for innovative construction materials and products. In 2015, Dr. Gong was elected as the Fellow of the International Academy of Wood Science (IAWS). Fellow of IAWS is internationally regarded as a very high honor in the wood science community in recognition of his/her achievements in wood science. Dr. Gong received the Merit Award from UNB in 2016. This award recognizes the outstanding performance, commitment and service to the University.
Dr. Ehab Misk is the Research Scientist at the Hunstman Marine Science Centre and joined in April of 2018. He holds a BSc and MSc in veterinary medicine from Assiut University (Assiut, Egypt) and a PhD in pathobiology from University of Guelph (Guelph, ON).
As the New Brunswick Innovation Research Chair in Aquatic Biosciences, Dr. Misk’s research to date has focused on fish disease surveillance, molecular diagnostics, regulation of innate immune response, and disease resistance. Such research has involved numerous viral and bacterial pathogens, including those that infect Atlantic salmon, rainbow trout, baitfish, shiners, minnows and suckers. Dr. Misk brings a wealth of experience to the Huntsman in developing controlled infection models associated with a range of freshwater and seawater pathogens that will be of interest to our diverse client base.
Dr. Misk is an expert and his skills and expertise fall under cell culture, gene expression, flow cytometry, molecular biology, immunology, innate immunity, virus etc. Dr. Misk has the critical expertise to ensure Huntsman’s reputation to be a leader in aquatic science research. Dr. Misk brings knowledge in developing controlled infection models associated with a range of freshwater and seawater pathogens – such as fungus like Saprolegnia sp., bacteria such as Mycobacterium sp. and Flavobacterium sp., and viruses such as Spring Viremia of Carp Virus (SVCS) and Viral Haemorrhagic Septicemia Virus (VHSV) – that will be of interest to the Huntsman’s diverse client base. Dr. Misk has the experience to conduct all levels of fish health assessment, including post-mortem examination, microbiology, virology, histopathology, molecular diagnostics, and reporting.